Sarah Gheuens sold $296K of Agios Pharmaceuticals (AGIO)

Executed Oct 26, disclosed Oct 28, 2 days later.

Value, as filed

$296K

7,866 sh × $37.69

Executed

Oct 26

the trade date, as filed

Disclosed

Oct 28

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Sarah Gheuens Chief Medical Officer profile →

Sarah Gheuens (Chief Medical Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $914K of AGIO (30,000 sh × $30.48, as filed), executed Aug 4.

The name

AGIO

Agios Pharmaceuticals, Inc. AGIO · Healthcare · 29 filings in 24 months ticker →

Healthcare · Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the Unite…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Sarah Gheuens in AGIO

AGIOSALE Agios Pharmaceuticals, Inc. $914K
30,000 sh × $30.48
Exec Aug 4
Filed Aug 6 · 4:13 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $151K
4,007 sh × $37.56
Exec Jul 1
Filed Jul 2 · 4:03 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $102K
2,940 sh × $34.71
Exec Apr 2
Filed Apr 6 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $107K
2,454 sh × $43.78
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $145K
3,302 sh × $43.92
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $420K
11,067 sh × $37.93
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. $140K
4,091 sh × $34.17
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET